Color-coded fluorescence imaging of tumor-host interactions (original) (raw)
- Protocol
- Published: 03 August 2006
Nature Protocols volume 1, pages 928–935 (2006)Cite this article
- 789 Accesses
- 162 Citations
- Metrics details
Abstract
Fluorescent proteins have the properties of being very bright with high quantum yield and are available in many colors. Tumor-host models consist of transgenic mice expressing green fluorescent protein (GFP) in essentially all cells and tissues or expressing GFP selectively in specific tissues such as blood vessels. Particularly useful are the corresponding nude mice transgenic for GFP expression, as they can accept human tumors. When tumor cells expressing red fluorescent protein are implanted in mice expressing GFP, various types of tumor-host interactions can be observed, including those involving host blood vessels, lymphocytes, tumor-associated fibroblasts, macrophages, dendritic cells and others. The 'color-coded' tumor-host models enable imaging and therefore a deeper understanding of the host cells involved and their function in tumor progression. Approximately 4–8 weeks are needed for these procedures.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Hoffman, R.M. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat. Rev. Cancer 5, 796–806 (2005).
Article CAS Google Scholar - Yang, M. et al. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc. Natl. Acad. Sci. USA 100, 14259–14262 (2003).
Article CAS Google Scholar - Yang, M. et al. Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors. Cancer Res. 64, 8651–8656 (2004).
Article CAS Google Scholar - Amoh, Y. et al. Hair follicle-derived blood vessels vascularize tumors in skin and are inhibited by doxorubicin. Cancer Res. 65, 2337–2343 (2005).
Article CAS Google Scholar - Amoh, Y. et al. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res. 65, 5352–5357 (2005).
Article CAS Google Scholar - Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. & Nishimune, Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313–319 (1997).
Article CAS Google Scholar - Amoh, Y. et al. Nascent blood vessels in the skin arise from nestin-expressing hair follicle cells. Proc. Natl. Acad. Sci. USA 101, 13291–13295 (2004).
Article CAS Google Scholar - Hoffman, R.M. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest. New Drugs 17, 343–359 (1999).
Article CAS Google Scholar - Hoffman, R.M. In vivo imaging with fluorescent proteins: The new cell biology. Acta Histochem. 106, 77–87 (2004).
Article CAS Google Scholar
Author information
Authors and Affiliations
- AntiCancer, 7917 Ostrow Street, San Diego, 92111, California, USA
Robert M Hoffman & Meng Yang - Department of Surgery, University of California, San Diego, 200 West Arbor Drive, San Diego, 92103-8220, California, USA
Robert M Hoffman
Authors
- Robert M Hoffman
- Meng Yang
Corresponding author
Correspondence toRobert M Hoffman.
Ethics declarations
Competing interests
R.M.H. is the president of AntiCancer, which has commercial activities in the area of fluorescent protein–based imaging and has a Technology Development with Olympus.
Supplementary information
Rights and permissions
About this article
Cite this article
Hoffman, R., Yang, M. Color-coded fluorescence imaging of tumor-host interactions.Nat Protoc 1, 928–935 (2006). https://doi.org/10.1038/nprot.2006.119
- Published: 03 August 2006
- Issue date: August 2006
- DOI: https://doi.org/10.1038/nprot.2006.119